173 related articles for article (PubMed ID: 19011639)
21. Mechanisms of neurodegeration in type 2 diabetes and the neuroprotective potential of dipeptidyl peptidase 4 inhibitors.
Matteucci E; Giampietro O
Curr Med Chem; 2015; 22(13):1573-81. PubMed ID: 25723507
[TBL] [Abstract][Full Text] [Related]
22. Dipeptidyl peptidase-4 inhibition improves endothelial senescence by activating AMPK/SIRT1/Nrf2 signaling pathway.
Chen Z; Yu J; Fu M; Dong R; Yang Y; Luo J; Hu S; Li W; Xu X; Tu L
Biochem Pharmacol; 2020 Jul; 177():113951. PubMed ID: 32251672
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of DPP4 enhances inhibitory synaptic transmission through activating the GLP-1/GLP-1R signaling pathway in a rat model of febrile seizures.
Zhang Y; Liu Y; Xu J; Sun Q; Yu F; Cheng J; Peng B; Liu W; Xiao Z; Yin J; Han S; He X
Biochem Pharmacol; 2018 Oct; 156():78-85. PubMed ID: 30086287
[TBL] [Abstract][Full Text] [Related]
24. Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else?
Juillerat-Jeanneret L
J Med Chem; 2014 Mar; 57(6):2197-212. PubMed ID: 24099035
[TBL] [Abstract][Full Text] [Related]
25. Crystal structures of a bacterial dipeptidyl peptidase IV reveal a novel substrate recognition mechanism distinct from that of mammalian orthologues.
Roppongi S; Suzuki Y; Tateoka C; Fujimoto M; Morisawa S; Iizuka I; Nakamura A; Honma N; Shida Y; Ogasawara W; Tanaka N; Sakamoto Y; Nonaka T
Sci Rep; 2018 Feb; 8(1):2714. PubMed ID: 29426867
[TBL] [Abstract][Full Text] [Related]
26. Prolyl peptidases related to dipeptidyl peptidase IV: potential of specific inhibitors in drug discovery.
Van der Veken P; Haemers A; Augustyns K
Curr Top Med Chem; 2007; 7(6):621-35. PubMed ID: 17352682
[TBL] [Abstract][Full Text] [Related]
27. SVMDLF: A novel R-based Web application for prediction of dipeptidyl peptidase 4 inhibitors.
Chandra S; Pandey J; Tamrakar AK; Siddiqi MI
Chem Biol Drug Des; 2017 Dec; 90(6):1173-1183. PubMed ID: 28585374
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of dipeptidyl peptidase IV in human versus cynomolgus monkey skin eccrine sweat glands.
Pantano S; Dubost V; Darribat K; Couttet P; Grenet O; Busch S; Moulin P
J Mol Histol; 2013 Dec; 44(6):733-47. PubMed ID: 23880984
[TBL] [Abstract][Full Text] [Related]
29. Discovery of dipeptidyl peptidase 4 inhibitory peptides from Largemouth bass (Micropterus salmoides) by a comprehensive approach.
Wang K; Yang X; Lou W; Zhang X
Bioorg Chem; 2020 Dec; 105():104432. PubMed ID: 33157343
[TBL] [Abstract][Full Text] [Related]
30. Development of a
Yazbeck R; Jaenisch S; Squire M; Abbott CA; Parkinson-Lawrence E; Brooks DA; Butler RN
Sci Rep; 2019 Mar; 9(1):4906. PubMed ID: 30894647
[TBL] [Abstract][Full Text] [Related]
31. The role of Dipeptidyl Peptidase-4 in cutaneous disease.
Patel PM; Jones VA; Kridin K; Amber KT
Exp Dermatol; 2021 Mar; 30(3):304-318. PubMed ID: 33131073
[TBL] [Abstract][Full Text] [Related]
32. Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions.
Sternkopf M; Nagy M; Baaten CCFMJ; Kuijpers MJE; Tullemans BME; Wirth J; Theelen W; Mastenbroek TG; Lehrke M; Winnerling B; Baerts L; Marx N; De Meester I; Döring Y; Cosemans JMEM; Daiber A; Steven S; Jankowski J; Heemskerk JWM; Noels H
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):e65-e77. PubMed ID: 31893947
[TBL] [Abstract][Full Text] [Related]
33. The effects of dipeptidyl peptidase-4 inhibition on microvascular diabetes complications.
Avogaro A; Fadini GP
Diabetes Care; 2014 Oct; 37(10):2884-94. PubMed ID: 25249673
[TBL] [Abstract][Full Text] [Related]
34. A novel multi-epitope vaccine based on Dipeptidyl Peptidase 4 prevents streptozotocin-induced diabetes by producing anti-DPP4 antibody and immunomodulatory effect in C57BL/6J mice.
Li Z; Fang J; Jiao R; Wei X; Ma Y; Liu X; Cheng P; Li T
Biomed Pharmacother; 2017 May; 89():1467-1475. PubMed ID: 28376584
[TBL] [Abstract][Full Text] [Related]
35. Possible ligand release pathway of dipeptidyl peptidase IV investigated by molecular dynamics simulations.
Li C; Shen J; Li W; Lu C; Liu G; Tang Y
Proteins; 2011 Jun; 79(6):1800-9. PubMed ID: 21465558
[TBL] [Abstract][Full Text] [Related]
36. Glycosylation of mouse DPP4 plays a role in inhibiting Middle East respiratory syndrome coronavirus infection.
Peck KM; Cockrell AS; Yount BL; Scobey T; Baric RS; Heise MT
J Virol; 2015 Apr; 89(8):4696-9. PubMed ID: 25653445
[TBL] [Abstract][Full Text] [Related]
37. Adaptive Evolution of MERS-CoV to Species Variation in DPP4.
Letko M; Miazgowicz K; McMinn R; Seifert SN; Sola I; Enjuanes L; Carmody A; van Doremalen N; Munster V
Cell Rep; 2018 Aug; 24(7):1730-1737. PubMed ID: 30110630
[TBL] [Abstract][Full Text] [Related]
38. Degradation of Incretins and Modulation of Blood Glucose Levels by Periodontopathic Bacterial Dipeptidyl Peptidase 4.
Ohara-Nemoto Y; Nakasato M; Shimoyama Y; Baba TT; Kobayakawa T; Ono T; Yaegashi T; Kimura S; Nemoto TK
Infect Immun; 2017 Sep; 85(9):. PubMed ID: 28630069
[TBL] [Abstract][Full Text] [Related]
39. Hematopoietic cell- versus enterocyte-derived dipeptidyl peptidase-4 differentially regulates triglyceride excursion in mice.
Varin EM; Hanson AA; Beaudry JL; Nguyen MA; Cao X; Baggio LL; Mulvihill EE; Drucker DJ
JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32663193
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer.
Nazarian A; Lawlor K; Yi SS; Philip J; Ghosh M; Yaneva M; Villanueva J; Saghatelian A; Assel M; Vickers AJ; Eastham JA; Scher HI; Carver BS; Lilja H; Tempst P
Mol Cell Proteomics; 2014 Nov; 13(11):3082-96. PubMed ID: 25056937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
